China's appeal as a location for clinical trials is well documented, but there are some hurdles to clear before a pharma company can successfully tap into its resources.
Sarah Houlton outlines the deals, collaborations and controversies that shaped the pharmaceutical industry in 2007, and examines how the land lies as we prepare for 2008.
The global pharmaceutical market is set to double in value by 2020. But the industry must transform itself if it is to capitalize on the forthcoming opportunities.
Pharmaceutical Executive Europe
The global pharmaceutical market is set to double in value by 2020. But the industry must transform itself if it is to capitalize on the forthcoming opportunities, says Steve Arlington.
In light of the British Medical Journal's controversial article asserting that pharma KOLs are no more than glorified sales reps, do you think there should be more transparency in industry's dealings with influential doctors?
Yes
60%
No
17%
This warrants further investigation first
24%
Thank you for voting
NEW SUPPLEMENT! Global Healthcare Marketing
SUMMARY: A round-up of the latest news, events and insightful editorial on the theme of R&D in the European pharmaceutical industry.
